KNOREX Ltd. is facing significant challenges as it has been notified of a trading suspension and potential delisting from NYSE American due to low share prices. The company announced on November 11, 2026, that the Exchange's staff has suspended trading in its Class A ordinary shares. This decision is a critical moment for KNOREX, which is known for its AI-driven programmatic advertising solutions.

The suspension and potential delisting highlight ongoing difficulties within the technology sector, particularly for companies involved in computer programming and data processing. The NYSE American cited Section 1003(f)(v) of its Company Guide as the basis for this action, emphasizing the low selling price of KNOREX’s shares.

Founded in 2009, KNOREX Ltd. operates as a B2B technology company that provides AI-driven marketing automation and digital advertising solutions. The company’s flagship platform, KNOREX XPO, allows businesses to optimize their digital marketing efforts across various channels. KNOREX is listed on the NYSE under the ticker KNRX.

In its recent filing, KNOREX stated, "The Exchange has determined to commence proceedings to delist the Class A ordinary shares of the Company." The company has until November 18, 2026, to appeal the delisting decision. It intends to request a hearing before a Listing Qualifications Panel, which will review the case.

During the appeal process, trading of KNOREX shares will remain suspended on the NYSE American. However, the company’s shares will continue to be listed while the appeal is pending. KNOREX plans to seek a reverse stock split as a potential measure to support its appeal and maintain compliance with the exchange’s listing standards. This move, if successful, would not alter shareholders' percentage ownership but could increase the share price.

The company remains focused on its operations and has emphasized its commitment to corporate governance and compliance. It plans to keep stakeholders informed of any developments regarding the appeal and the status of its shares.

As the situation develops, it could have implications not only for KNOREX but also for other companies in the computer programming and data processing sector, as they navigate similar challenges in maintaining their listings.

For further updates, KNOREX will provide additional information as necessary, ensuring transparency throughout this process.